-
-
-
-
-
-
-
Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides Financial Expectations for 2023
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Misses Q1 EPS by 5c
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Earnings Preview by Needham: Focus on Ingrezza Growth and Pipeline
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Tops Q2 EPS by 14c
-
-
-
-
-
-
-
Neurocrine Biosciences (NBIX) Tops Q4 EPS by 37c
-
-
-
-
-
-
-
After-Hours Stock Movers 11/09: (XPER) (FLGT) (HDS) Higher; (BYND) (NBIX) (TXMD) Lower (more...)
-
974,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All